The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,153,795 in first-year total cost, median $2,836,708.
Most frequent study sections
- Special Emphasis Panel[ZGM1 PPBC-Y (PG)]3
Most frequent institutions
- CHILDREN'S HOSPITAL & RES CTR AT OAKLAND1
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL1
- VANDERBILT UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Center for Precision Medicine in Leukemia (CPML)1P50GM115279-01 | LOH, MIGNON LEE-CHEUNRELLING, MARY V | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $3,138,729 | ZGM1 |
| 2015 | Pharmacogenomics of Statin Therapy1P50GM115318-01 | KRAUSS, RONALD MLUSIS, ALDONS JAKE | CHILDREN'S HOSPITAL & RES CTR AT OAKLAND, CA | $2,836,708 | ZGM1 |
| 2015 | Improving Prediction of Drug Action1P50GM115305-01 | DENNY, JOSHUA C.PHILLIPS, ELIZABETHRODEN, DAN M | VANDERBILT UNIVERSITY, TN | $1,178,358 | ZGM1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.